- Home
- DGX vs EQR Comparison
DGX vs EQR Comparison
Compare DGX & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DGX | EQR |
|---|---|---|
| Founded | 1967 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 24.3B |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DGX | EQR |
|---|---|---|
| Price | $195.15 | $58.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $208.62 | $69.58 |
| AVG Volume (30 Days) | 622.7K | ★ 2.0M |
| Earning Date | 04-21-2026 | 04-28-2026 |
| Dividend Yield | 1.74% | ★ 4.72% |
| EPS Growth | ★ 13.78 | 8.09 |
| EPS | ★ 8.75 | 2.94 |
| Revenue | ★ $11,035,000,000.00 | $2,701,075,000.00 |
| Revenue This Year | $7.53 | $4.17 |
| Revenue Next Year | $3.77 | $3.10 |
| P/E Ratio | $22.59 | ★ $20.23 |
| Revenue Growth | ★ 11.78 | 4.76 |
| 52 Week Low | $157.20 | $57.57 |
| 52 Week High | $213.50 | $72.40 |
Technical Indicators
Market Signals| Indicator | DGX | EQR |
|---|---|---|
| Relative Strength Index (RSI) | 42.19 | 38.55 |
| Support Level | $194.77 | $58.62 |
| Resistance Level | $197.55 | $64.20 |
| Average True Range (ATR) | 4.18 | 1.16 |
| MACD | -0.81 | -0.14 |
| Stochastic Oscillator | 18.14 | 22.12 |
Price Performance
Historical ComparisonAbout DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 318 apartment communities with over 86,000 units and is developing three additional properties with 935 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.